- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
GreenLight Biosciences (NASDAQ:GRNA), Quotes and News Summary
GreenLight Biosciences (NASDAQ: GRNA)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-07 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-19 | ||||||
| REV | |||||||
GreenLight Biosciences Questions & Answers
You can purchase shares of GreenLight Biosciences (NASDAQ: GRNA) through any online brokerage.
Other companies in GreenLight Biosciences’s space includes: Immunovant (NASDAQ:IMVT), Centessa Pharmaceuticals (NASDAQ:CNTA), Eagle Pharmaceuticals (NASDAQ:EGRX), Altimmune (NASDAQ:ALT) and Inovio Pharmaceuticals (NASDAQ:INO).
There is no analysis for GreenLight Biosciences
The stock price for GreenLight Biosciences (NASDAQ: GRNA) is $3.63 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for GreenLight Biosciences.
GreenLight Biosciences’s Q3 earnings are confirmed for Monday, November 7, 2022.
There is no upcoming split for GreenLight Biosciences.
GreenLight Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.